SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-052079
Filing Date
2015-08-26
Accepted
2015-08-26 17:18:26
Documents
5
Period of Report
2015-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v419204_8-k.htm 8-K 20401
2 EXHIBIT 10.1 v419204_ex10-1.htm EX-10.1 77576
3 EXHIBIT 10.2 v419204_ex10-2.htm EX-10.2 111196
4 EXHIBIT 99.1 v419204_ex99-1.htm EX-99.1 10725
6 GRAPHIC header.jpg GRAPHIC 13160
  Complete submission text file 0001144204-15-052079.txt   239424
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 151076620
SIC: 2835 In Vitro & In Vivo Diagnostic Substances